Form 4 for LXRX LEXICON PHARMACEUTICALS, INC.
Accepted 2023-03-01 00:00:00 ET · period of report 2023-02-28 · accession 0001127602-23-007932 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-01 | 2023-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | F - Tax | $2.17 | -11.8K | 53.1K | -18% | -$25.6K |
| DM | 2023-03-01 | 2023-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | +43.1K | 36.7K | New | — |
| DM | 2023-03-01 | 2023-02-28 | LXRX | Seth Kiernan | VP, Chief Commercial Off | M - OptEx | — | -43.1K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | F | D | 11,813 | $2.17 | 53,136 | D | — | — | |
| 2 | Common | Common Stock | 2023-02-28 | M | A | 5,286 | — | 41,986 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 3 | Common | Common Stock | 2023-02-28 | M | A | 22,963 | — | 64,949 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 4 | Common | Common Stock | 2023-02-28 | M | A | 14,833 | — | 36,700 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. |
| 5 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 5,286 | — | 5,287 | D | — · — to — | 5,286 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 6 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 22,963 | — | 45,927 | D | — · — to — | 22,963 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |
| 7 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 14,833 | — | 0 | D | — · — to — | 14,833 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of common stock. (F3) Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant. |